Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CHEANYSE:ENPCNASDAQ:OACCNASDAQ:RENE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHEAChenghe Acquisition$5.58$5.62$4.70▼$12.15$63.11M0.02719,579 shs42,269 shsENPCExecutive Network Partnering$5.65+1.4%$5.37$8.46▼$10.24$237.38M-0.04245,839 shs398,381 shsOACCOaktree Acquisition Corp. III Life Sciences$10.45-0.1%$10.23$9.95▼$10.85$234.57MN/A95,922 shs2,925 shsRENECartesian Growth Co. II$11.75$11.87$11.22▼$11.95$254.05M-0.0189,787 shs1 shs10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHEAChenghe Acquisition0.00%0.00%0.00%0.00%0.00%ENPCExecutive Network Partnering+1.44%+9.07%+15.07%-9.16%-14.78%OACCOaktree Acquisition Corp. III Life Sciences0.00%+0.48%+3.36%+4.40%+1,044,999,900.00%RENECartesian Growth Co. II0.00%-1.34%-1.47%-0.34%+4.72%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCHEAChenghe AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AENPCExecutive Network PartneringN/AN/AN/AN/AN/AN/AN/AN/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AN/AN/AN/ARENECartesian Growth Co. IIN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHEAChenghe Acquisition 0.00N/AN/AN/AENPCExecutive Network Partnering 0.00N/AN/AN/AOACCOaktree Acquisition Corp. III Life Sciences 0.00N/AN/AN/ARENECartesian Growth Co. II 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHEAChenghe AcquisitionN/AN/AN/AN/AN/AN/AENPCExecutive Network PartneringN/AN/A$0.02 per share268.01($0.20) per shareN/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AN/ARENECartesian Growth Co. IIN/AN/A$0.40 per share29.45($0.64) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHEAChenghe AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/AENPCExecutive Network Partnering$1.47MN/A0.003.95N/AN/A-74.23%-2.27%N/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/A0.00∞N/AN/AN/AN/AN/ARENECartesian Growth Co. II$11.44MN/A0.00∞N/AN/A-51.08%5.43%5/21/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHEAChenghe AcquisitionN/AN/AN/AN/AN/AENPCExecutive Network PartneringN/AN/AN/AN/AN/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/ARENECartesian Growth Co. IIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHEAChenghe AcquisitionN/AN/AN/AENPCExecutive Network PartneringN/A0.020.02OACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/ARENECartesian Growth Co. IIN/A0.090.09Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHEAChenghe Acquisition75.35%ENPCExecutive Network Partnering88.58%OACCOaktree Acquisition Corp. III Life SciencesN/ARENECartesian Growth Co. II58.96%Insider OwnershipCompanyInsider OwnershipCHEAChenghe Acquisition24.40%ENPCExecutive Network Partnering0.17%OACCOaktree Acquisition Corp. III Life SciencesN/ARENECartesian Growth Co. II26.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHEAChenghe AcquisitionN/A11.31 million8.55 millionNot OptionableENPCExecutive Network Partnering142.01 million41.94 millionNot OptionableOACCOaktree Acquisition Corp. III Life SciencesN/A22.43 millionN/AN/ARENECartesian Growth Co. II221.62 million15.87 millionNot OptionableCHEA, RENE, ENPC, and OACC HeadlinesRecent News About These CompaniesCantor Fitzgerald L. P. Makes New $22.13 Million Investment in Cartesian Growth Co. II (NASDAQ:RENE)May 7, 2025 | marketbeat.comCartesian Growth Co. II (NASDAQ:RENE) Shares Sold by Berkley W R CorpMay 1, 2025 | marketbeat.comCrossingbridge Advisors LLC Sells 578,152 Shares of Cartesian Growth Co. II (NASDAQ:RENE)April 28, 2025 | marketbeat.comSpartan Fund Management Inc. Takes Position in Cartesian Growth Co. II (NASDAQ:RENE)April 25, 2025 | marketbeat.comAlpine Global Management LLC Invests $2.33 Million in Cartesian Growth Co. II (NASDAQ:RENE)April 24, 2025 | marketbeat.comCartesian Growth Co. II (NASDAQ:RENE) Shares Down 0% - Time to Sell?April 20, 2025 | marketbeat.comCartesian Growth Corp II extends business combination periodMarch 5, 2025 | investing.comCartesian Growth Corp II extends business combination deadlineFebruary 5, 2025 | msn.comPositive Buy Rating for Cartesian Therapeutics Amid Encouraging Developments in Descartes-08 TrialsJanuary 28, 2025 | markets.businessinsider.comCartesian Growth Corporation IIDecember 23, 2024 | investing.comBertrand P. Grabowski's Net WorthNovember 2, 2024 | benzinga.comRENE’s Unexpected Plunge: What’s Next?October 31, 2024 | bovnews.comHow to Take Advantage of moves in (RENE)August 22, 2024 | news.stocktradersdaily.comMedia Sentiment Over TimeTop HeadlinesView All HeadlinesQualcomm Is 5x Cheaper Than AMD, But Won’t Be for LongBy Sam Quirke | May 13, 2025View Qualcomm Is 5x Cheaper Than AMD, But Won’t Be for Long3 Undervalued Stocks Wall Street Is Getting WrongBy Gabriel Osorio-Mazilli | May 12, 2025View 3 Undervalued Stocks Wall Street Is Getting WrongThe 6 Best Energy Stocks to Buy NowBy Dan Schmidt | April 25, 2025View The 6 Best Energy Stocks to Buy NowIs Intel Stock a Bargain or a Burden? Cheap Stock, High StakesBy Jeffrey Neal Johnson | May 7, 2025View Is Intel Stock a Bargain or a Burden? Cheap Stock, High StakesSurvey: America’s Most Inspirational Women Business Leaders [2025]By MarketBeat Staff | May 7, 2025View Survey: America’s Most Inspirational Women Business Leaders [2025]CHEA, RENE, ENPC, and OACC Company DescriptionsChenghe Acquisition NASDAQ:CHEAChenghe Acquisition Co. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business opportunities in the field of financial technology or technology-enabled financial service companies, including artificial intelligence, big data, and cloud and blockchain-related initiatives in Asian markets. Chenghe Acquisition Co. was founded in 2021 and is based in Singapore.Executive Network Partnering NYSE:ENPC$5.65 +0.08 (+1.44%) As of 05/16/2025Executive Network Partnering Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar partnering transaction with one or more businesses. The company was incorporated in 2020 and is based in Boston, Massachusetts.Oaktree Acquisition Corp. III Life Sciences NASDAQ:OACC$10.45 -0.01 (-0.10%) As of 05/16/2025 04:00 PM EasternOaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.Cartesian Growth Co. II NASDAQ:RENE$11.75 0.00 (0.00%) As of 05/13/2025Cartesian Growth Corp. II operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on October 13, 2021 and is headquartered in New York, NY. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/12 - 05/16 Retail Investors Are Betting Big on Rocket Lab—Should You Too? Meta's 5 Key Pillars for AI Growth—Zuckerberg's Bold Vision Taiwan Semiconductor Stock Is The Gift That Keeps on Giving GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine Alibaba's Earnings Just Changed Everything for the Stock Plug Power: Is Q1 Noise An Opportunity for Accumulation? Cisco Stock Eyes New Highs in 2025 on AI, Earnings, Upgrades Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
